Conditions: Acne Vulgaris
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1555
Healthy volunteers: no

Brief summary:
The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel (Clindamycin- Benzoyl Peroxide Gel).

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: Clindamycin 1% / Benzoyl Peroxide 5% (Perrigo) intervention 2: Clindamycin 1% / Benzoyl Peroxide 5% (Benzaclin) intervention 3: Placebo
Intervention descriptions: intervention 1: Applied to the entire face twice daily for 10 weeks intervention 2: Applied to the entire face twice daily for 10 weeks intervention 3: Placebo

Protocol document: